A Diagnostic Analysis Workflow to Optimal Multiple Tumor Markers to Predict the Nonmetastatic Breast Cancer from Breast Lumps

Figure 2

The expression levels of five differentiating tumor biomarkers between breast cancer patients and benign breast disease patients. The start means a significant difference between breast cancer patients compared to benign breast disease patients.

(a)

(b)

(c)

(d)

(e)